Although previous studies reported increased IL-6 CSF levels in NMOSD patients [22] and some associations with more severe clinical and cognitive deficits [23], we did not observe differences in IL-6 levels between NMOSD AQP4 + patients, RRMS patients, and NIC. This evidence concerns the gene AQP4 and Cognitive impairment.